Ovid Therapeutics OVID paid The KPM Group DC $20K for lobbying in Q1 2023

Trade details

Type: Lobbying report
Amount: $20,000
Quarter: Q1 2023
Stock: Ovid Therapeutics OVID
Client: Ovid Therapeutics
Reported: 23/04/20

Up 0.0% from last quarter

What else happened in Ovid Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Ovid Therapeutics's other lobbying reports

Ovid Therapeutics
LobbyingOvid Therapeutics
Lobbying
Ovid Therapeutics
OVID
$20K
$20K
Reported 23/01/19
for Q4 2022

Ovid Therapeutics OVID paid The KPM Group DC $20K for lobbying in Q1 2023 | Whalegun